Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-04

FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved the Sun Pharmaceutical supplemental application for a generic pentazocine and naloxone product. It's an analgesic combination intended to treat acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentazocine and Naloxone (Pentazocine hydrochloride and naloxone hydrochloride)

Snippet

SUPPL AP for PENTAZOCINE AND NALOXONE (PENTAZOCINE AND NALOXONE)